Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Reuben Gregg Brewer - Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven-Figure Retirement
Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven-Figure Retirement
The Motley Fool

The S&P 500 index (^GSPC 0.43%) is offering a tiny 1.1% dividend yield today. The average pharmaceutical stock yields around 1.7%. Bristol Myers Squibb (BMY +2.08%), however, is offering investors a yield of 4%. If you're a dividend investor…

mediabistro.com - Media News - New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM EST
Mediabistro

The Show Will Also Air Across Latin America and MENA 1230 pm local time. New to The Street will broadcast nationally tonight at 6:30 PM EST on Bloomberg Television, featuring executive leadership interviews with Medicus Pharma Ltd. (NASDAQ:MDCX)…

marketbeat.com - Monashee Investment Management LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
Monashee Investment Management LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Monashee Investment Management LLC lessened its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 21.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange…

marketbeat.com - Urogen Pharma (NASDAQ:URGN) Given Consensus Rating of 'Moderate Buy' by Analysts
Urogen Pharma (NASDAQ:URGN) Given Consensus Rating of 'Moderate Buy' by Analysts
MarketBeat

Urogen Pharma (NASDAQ:URGN - Get Free Report) has been assigned an average recommendation of 'Moderate Buy' from the eight research firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell…

marketbeat.com - Okabena Investment Services Inc. Makes New $816,000 Investment in BridgeBio Pharma, Inc. $BBIO
Okabena Investment Services Inc. Makes New $816,000 Investment in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Okabena Investment Services Inc. acquired a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired…

techcrunch.com - Connie Loizos - The trap Anthropic built for itself
The trap Anthropic built for itself
TechCrunch

Friday afternoon, just as this interview was getting underway, a news alert flashed across my computer screen: the Trump administration was severing ties with Anthropic, the San Francisco AI company founded in 2021 by Dario Amodei and other former…

mirror.co.uk - Frances Kindon - I'm a Brit trapped in Dubai with kids cowering from smoke and eerie bangs
I'm a Brit trapped in Dubai with kids cowering from smoke and eerie bangs
The Mirror

Saturdays in Dubai usually are a time for sun, shopping and brunches - not bombs and missiles. But as the mercury hit 28C yesterday afternoon, the Emirates city - named 2025's 'second safest in the world ' - was transformed into a zone of terror as…

fool.com - Reuben Gregg Brewer - Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
The Motley Fool

Eli Lilly (LLY +2.93%) is growing very quickly right now thanks to Mounjaro and Zepbound, its two GLP-1 drugs, the latter of which is approved for weight loss. Mounjaro's sales rose 99% in 2025, and Zepbound's sales were up a shocking 175%. But…

express.co.uk - Chris Riches - NHS wonder drug saved my sick lungs - now I'm running a marathon
NHS wonder drug saved my sick lungs - now I'm running a marathon
Express.co.uk

The Express started campaigning for CF sufferers in February 2019 and by October of that year the first two main drugs by US pharma giant Vertex - Orkambi and Symkevi - became available to UK patients. By the summer of 2020 the third wonder…

yahoo.com - Ricardo Pillai - Erasca, Inc. (ERAS): A Bull Case Theory
Erasca, Inc. (ERAS): A Bull Case Theory
Yahoo!

We came across a bullish thesis on Erasca, Inc. on Danny's Substack by Danny Green. In this article, we will summarize the bulls' thesis on ERAS. Erasca, Inc.'s share was trading at $12.39 as of February 19th. Photo by National Cancer Institute on…

fool.com - Katie Brockman - River Road Loads Up on ATR With 917,000 Shares in New Position
River Road Loads Up on ATR With 917,000 Shares in New Position
The Motley Fool

According to a Securities and Exchange Commission (SEC) filing dated February 24, 2026, River Road Asset Management, LLC established a new position in AptarGroup (ATR +1.35%) by acquiring 917,670 shares. The estimated value of this trade is $111.92…

republicworld.com - Asian News International - PM Modi Targets Congress, Says Oppn Party Worked as 'Speedbreaker' in Puducherry's Growth
PM Modi Targets Congress, Says Oppn Party Worked as 'Speedbreaker' in Puducherry's Growth
Republic World

Puducherry: Prime Minister Narendra Modi, on Sunday, took aim at the Congress and said that the opposition party had created a 'speedbreaker in the growth of Puducherry'. Years of Congress rule were marked by corruption, crime and suffering of the…

cyclingnews.com - Matilda Price - Giro di Sardegna: Filippo Zana takes home overall victory as Davide Donati speeds to final stage win
Giro di Sardegna: Filippo Zana takes home overall victory as Davide Donati speeds to final stage win
Cyclingnews

It was double Italian victory in the Giro di Sardegna on Sunday, with Filippo Zana (Soudal-QuickStep) sealing the GC title after his Queen stage triumph, whilst Davide Donati (Red Bull-Bora-Hansgrohe Rookies) conquered the final sprint. Donati came…

thehoya.com - Sasha Ahmad - ON THE PERIPHERY | Immigration Status as a Health Determinant
ON THE PERIPHERY | Immigration Status as a Health Determinant
The Hoya

In the past year, there has been a lot of news and discourse over undocumented immigrants, civil rights, and immigration enforcement in the United States. A more neglected question is that of immigrant healthcare. I'm sure we have all, to some…

om.co - What To Read This Weekend
What To Read This Weekend
On my Om

Okay, this might be the N+1 attempt to rekindle this newsletter format. I start with good intentions, but always fail at maintaining continuity. I am going to give this one more try, and see how it goes. As Yoda said, “Do. Or do not. There…

Receive a Daily briefing on Pharma Industry News

Get Started